Canaccord analyst Kyle Mikson lowered the firm’s price target on Illumina to $300 from $330 and keeps a Buy rating on the shares. The analyst noted 4Q22 results were generally in line with Street estimates, although the 2023 outlook was below expectations and the company’s 2023 adjusted EPS outlook was particularly soft given multiple factors that are mostly external and out of the company’s control.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on ILMN:
- Illumina to face EU fine of 10% of turnover due to Grail deal, Reuter says
- Illumina facing EU fine of 10% turnover over Grail deal, Reuters says
- Illumina Lower after Negative FY23 Outlook
- Illumina price target lowered to $210 from $220 at BofA
- Illumina price target lowered to $296 from $350 at Cowen